Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Management Satisfaction in Survivors of Testicular Cancer

TORE SØRLIE, JAN H. ROSENVINGE, ROY BREMNES, LISE BALTESKARD, ALV A. DAHL, OLBJØRN KLEPP and SOPHIE D. FOSSÅ
Anticancer Research March 2006, 26 (2B) 1463-1469;
TORE SØRLIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tore.sorlie{at}unn.no
JAN H. ROSENVINGE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROY BREMNES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LISE BALTESKARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALV A. DAHL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLBJØRN KLEPP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOPHIE D. FOSSÅ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The aim of this study was to examine satisfaction with the quality of the doctor-patient relationship (QCD) and the information (INF) made available, as well as the influence of different treatment modalities and psychosocial variables in testicular cancer survivors (TCSs). Materials and Methods: Two-hundred and 6 TCSs, seen at 2 Norwegian university hospitals, were studied retrospectively and currently in a cross-sectional follow-up design. Questionnaires were filled in prior to and at the patients' follow-up examination. The mean length of time since their management period had ended was 6.5 years (range 0-17 years). Results: The QCD was rated higher than the INF. The QCD was also the strongest contributor to the variance in the INF. The patients in the surveillance group had the lowest QCD. Conclusion: The relatively high QCD scores may reflect the fact that the patients had been cured from a life-threatening disease. The low INF scores may indicate that the TCSs were poorly informed about the potential health problems related to their treatment. Thus, it is suggested that more attention should be focused on the education of the patients.

  • Doctor-patient relationship
  • testicular cancer survivors

Footnotes

  • Received November 25, 2005.
  • Revision received January 30, 2006.
  • Accepted February 6, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 2B
March-April 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Management Satisfaction in Survivors of Testicular Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
20 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Management Satisfaction in Survivors of Testicular Cancer
TORE SØRLIE, JAN H. ROSENVINGE, ROY BREMNES, LISE BALTESKARD, ALV A. DAHL, OLBJØRN KLEPP, SOPHIE D. FOSSÅ
Anticancer Research Mar 2006, 26 (2B) 1463-1469;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Management Satisfaction in Survivors of Testicular Cancer
TORE SØRLIE, JAN H. ROSENVINGE, ROY BREMNES, LISE BALTESKARD, ALV A. DAHL, OLBJØRN KLEPP, SOPHIE D. FOSSÅ
Anticancer Research Mar 2006, 26 (2B) 1463-1469;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
  • Prognostic and Neurological Outcomes Following Surgery for Spinal NF2-Associated Ependymomas With Cysts
  • Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire